Independent sector cervical screening
Primary care colleagues have raised concerns regarding cervical cytology testing at independent facilities i.e. “private smear tests”. Cervical cytology samples undertaken in the IndependentSector are not part of the national screening programme. Colleagues felt it would be helpful if GPs/practices were made aware of the issue.
All eligible women (aged from 25-64) will automatically receive their invitation letter from the Primary Care Support (England), formerly called the ‘Call/Recall Agency’ to attend for screening. Women who have cervical samples taken outside the NHS cervical screening programme may contact their GP to say that they have had cervical cytology done privately. The GP/practice should then advise the woman that her private cervical cytology test results are not captured in the NHS screening programme and that she is eligible for her routine test and should attend for this.
However, please be aware that there should be a 3 month interval between any private sample and one taken as part of the NHSCSP to ensure an adequate sample has been taken.
Inappropriate and ‘out of programme’ samples
Recall intervals for cervical screening
Current guidance on inappropriate tests and symptomatic women is given in the NHSCSP guidelines, Colposcopy & Programme Management Publication No.20, Third Edition, March 2016.
- Routine 3 yearly recall between the ages of 24 years, 6 months to 49 years inclusive, unless previously invited by the Scottish, Welsh or Irish screening programmes
- Routine 5 yearly recall between the ages of 50 to 64 years inclusive
- Cease cervical screening at age 65 years, only screen those who:
i) Have never had a screening test and now request one
ii) Did not attend for their lest test when aged 60 or over and now wish to have that final test
iii) If the last 3 tests included an abnormal result and/or she is on follow-up for treatment of CIN/CGIN/invasive cancer
iv) Over 65 and had fewer than 3 consecutive negative tests
Abnormal looking cervix
If there is a clinical suspicion of cervical disease, cytology is not the appropriate test to investigate the symptoms. The woman should be referred urgently to colposcopy for investigation under the two-week-wait rule
Young women with abnormal bleeding
Women below the screening age range who present with symptoms such as postcoital bleeding or intermenstrual bleeding should be managed as per the latest recommendations in Clinical Practice Guidance for the Assessment of Young Women aged 20-24 with Abnormal Vaginal Bleeding. Cervical cytology does not form part of this management pathway. Note, this includes women under the age of 20 years.
Follow-up after total hysterectomy
Women who need vaginal vault sampling following surgery are not included in the NHS Cervical Screening Programme. Vault samples should be taken in a hospital setting e.g. colposcopy and therefore women requiring this should be referred to colposcopy or remain at colposcopy until all necessary vault samples have been taken.
The laboratory will reject vault samples taken in primary care.
The clinical indications for taking a vault sample are given in the NHSCSP guidelines, Colposcopy & Programme Management Publication No.20, Third Edition, March 2016.
(Last reviewed November 16th 2017)